Published in Biol Cell on July 01, 2008
A comprehensive comparison of transmembrane domains reveals organelle-specific properties. Cell (2010) 2.35
Claudin association with CD81 defines hepatitis C virus entry. J Biol Chem (2010) 1.67
Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics. Hepatology (2011) 1.54
Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells. J Virol (2009) 1.44
HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle. J Virol (2011) 1.37
IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology (2012) 1.36
Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner. Gastroenterology (2009) 1.17
Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection. Virol J (2009) 1.12
Regulation of bile canalicular network formation and maintenance by AMP-activated protein kinase and LKB1. J Cell Sci (2010) 1.06
Hepatocyte polarity. Compr Physiol (2013) 1.06
Primary hepatocytes as targets for hepatitis C virus replication. J Viral Hepat (2008) 1.03
Functional 3D human primary hepatocyte spheroids made by co-culturing hepatocytes from partial hepatectomy specimens and human adipose-derived stem cells. PLoS One (2012) 0.93
Cytokinesis defines a spatial landmark for hepatocyte polarization and apical lumen formation. J Cell Sci (2014) 0.91
Hepatoma polarization limits CD81 and hepatitis C virus dynamics. Cell Microbiol (2012) 0.90
AKAP350 Is involved in the development of apical "canalicular" structures in hepatic cells HepG2. J Cell Physiol (2012) 0.85
A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS One (2015) 0.84
In vitro systems for the study of hepatitis C virus infection. Int J Hepatol (2012) 0.82
Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies. Technology (Singap World Sci) (2015) 0.81
Build them up and break them down: Tight junctions of cell lines expressing typical hepatocyte polarity with a varied repertoire of claudins. Tissue Barriers (2013) 0.80
Induced pluripotent stem cells as a source of hepatocytes. Curr Pathobiol Rep (2014) 0.79
Differential basolateral-apical distribution of scavenger receptor, class B, type I in cultured cells and the liver. Histochem Cell Biol (2014) 0.79
Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry. World J Gastroenterol (2011) 0.78
Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease. World J Gastroenterol (2014) 0.77
Hepatocyte-like cells derived from induced pluripotent stem cells. Hepatol Int (2016) 0.76
Efficient generation of hepatic cells from mesenchymal stromal cells by an innovative bio-microfluidic cell culture device. Stem Cell Res Ther (2016) 0.75
Hepatitis c virus genotype 4 replication in the hepatocellular carcinoma cell line HepG2/C3A. Saudi J Gastroenterol (2016) 0.75
α1-antitrypsin deficiency and the hepatocytes - an elegans solution to drug discovery. Int J Biochem Cell Biol (2013) 0.75
Demonstration of the presence of the "deleted" MIR122 gene in HepG2 cells. PLoS One (2015) 0.75
A novel helper-dependent adenovirus-based cell culture model for Hepatitis C virus replication and production. Virol J (2013) 0.75
Regulatory subunit I-controlled protein kinase A activity is required for apical bile canalicular lumen development in hepatocytes. J Biol Chem (2009) 0.75
The special case of hepatocytes: unique tissue architecture calls for a distinct mode of cell division. Bioarchitecture (2014) 0.75
Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver. Sci Rep (2017) 0.75
ATP7B copper-regulated traffic and association with the tight junctions: copper excretion into the bile. Gastroenterology (2008) 1.48
Regulation of Ca(2+) signaling in rat bile duct epithelia by inositol 1,4,5-trisphosphate receptor isoforms. Hepatology (2002) 1.11
Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2. J Hepatol (2012) 0.99
Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta. Mol Pharmacol (2011) 0.98
The type 3 inositol 1,4,5-trisphosphate receptor is concentrated at the tight junction level in polarized MDCK cells. J Cell Sci (2003) 0.96
Hepatocyte targeting and intracellular copper chelation by a thiol-containing glycocyclopeptide. J Am Chem Soc (2010) 0.95
Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma. Gastroenterology (2006) 0.94
Claudin-1 involved in neonatal ichthyosis sclerosing cholangitis syndrome regulates hepatic paracellular permeability. Hepatology (2012) 0.90
Expression and regulation of gap junctions in rat cholangiocytes. Hepatology (2002) 0.88
Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2. J Hepatol (2010) 0.87
A sulfur tripod glycoconjugate that releases a high-affinity copper chelator in hepatocytes. Angew Chem Int Ed Engl (2012) 0.85
Interference of CuO nanoparticles with metal homeostasis in hepatocytes under sub-toxic conditions. Nanoscale (2014) 0.84
Detection of a raft-located estrogen receptor-like protein distinct from ER alpha. Int J Biochem Cell Biol (2005) 0.83
Iodide transporter NIS regulates cancer cell motility and invasiveness by interacting with the Rho guanine nucleotide exchange factor LARG. Cancer Res (2012) 0.83
How to induce non-polarized cells of hepatic origin to express typical hepatocyte polarity: generation of new highly polarized cell models with developed and functional bile canaliculi. Cell Tissue Res (2005) 0.81
Investigation of the hepatotoxicity profile of chemical entities using Liverbeads and WIF-B9 in vitro models. Toxicol In Vitro (2006) 0.81
Cytochrome P450 expression-induction profile and chemically mediated alterations of the WIF-B9 cell line. Biol Cell (2006) 0.80
Molecular pathology of Wilson's disease: a brief. J Hepatol (2010) 0.80
Immunohistological study of involucrin expression in Darier's disease skin. J Cutan Pathol (2008) 0.79
Cadmium disorganises the scaffolding of gap and tight junction proteins in the hepatic cell line WIF B9. Biol Cell (2013) 0.78
Efficacy and tolerance of systemic steroids in sciatica: a systematic review and meta-analysis. Rheumatology (Oxford) (2011) 0.78
The early noncoding region of human papillomavirus type 16 is regulated by cytoplasmic polyadenylation factors. Virus Res (2010) 0.76
Expression, localization, and inducibility by bile acids of hepatobiliary transporters in the new polarized rat hepatic cell lines, Can 3-1 and Can 10. Cell Tissue Res (2007) 0.76
Characterization of WIF-B9/R cells as an in vitro model with hepatocyte-like polarity and enhanced expression of canalicular ABC transporters involved in phase III of hepatic detoxification. Toxicology (2007) 0.75
Negative regulation of MAP kinase signaling in Drosophila by Ptp61F/PTP1B. Mol Genet Genomics (2014) 0.75